Navigation Links
DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
Date:11/15/2012

VANCOUVER, British Columbia, Nov. 15, 2012 /PRNewswire/ -- Del Mar Pharmaceuticals (BC) Ltd. ("DelMar Pharma") today announced that the Company will present two scientific posters at the Society for Neuro-Oncology (SNO) 17th Annual Scientific Meeting, which is being held in Washington, DC November 15-18, 2012. 

On Friday November 16th, DelMar will present a poster entitled, "VAL-083, Novel N7 Alkylating Agent, Surpasses Temozolomide Activity and Inhibits Cancer Stem Cells Providing a New Potential Treatment Option for Glioblastoma Multiforme".

On Saturday November 17th, DelMar will present a poster entitled, "Phase I/II Study of VAL-083 in Patients with Recurrent Malignant Glioma".

Jeffrey Bacha, President & CEO of DelMar Pharma stated, "We are pleased to present these data at the annual SNO meeting.  We believe our interim clinical data along with new non-clinical data being presented serve to differentiate VAL-083 from standard of care and demonstrate the drug's potential as a future treatment option for patients suffering from glioblastoma multiforme who have failed both front-line therapy with temozolomide (Temodar®) and have failed or are ineligible for second-line bevacizumab (Avastin®)."

Mr. Bacha noted that the data that will be presented from the first two cohorts in the Company's dose-escalating Phase I/II study support that VAL-083 is safe and well tolerated. An overall response rate of 28.5%, where tumor growth had stabilized or regressed, has been observed at doses investigated to date.

"While these data with VAL-083 are interim in nature, we are enthusiastic about the results to date.  We look forward to continuing to work with our clinical investigators toward determining an optimal dosing regimen for future registration trials and to the potential opportunity of offering patients a valuable new treatment o
'/>"/>

SOURCE Del Mar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900
2. Access Pharmaceuticals To Host Third Quarter Investor Call on Wednesday, November 28th
3. Ground Zero Pharmaceuticals, Inc. (GZP) Announces Enhanced Biosimilars and Personalized Medicine Initiatives for its Clients
4. Cardioxyl Pharmaceuticals Raises $28 Million In Series B Financing Led By OrbiMed Advisors
5. Savara Pharmaceuticals AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients
6. Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
7. Frost & Sullivan: Lack of Proper Price Regulation for Pharmaceuticals
8. Jazz Pharmaceuticals Announces Participation In Three Investor Conferences In November
9. Achillion Pharmaceuticals, Inc. Hosts the HCV Connection Media Briefing at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
10. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
11. Jazz Pharmaceuticals Announces Third Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Pa. , May 24, 2013  Auxilium Pharmaceuticals, ... executive management will participate in the Deutsche Bank Health ... Westin Boston Waterfront Hotel.  Mr. Adrian Adams ... to present an overview of the Company and its ... 29, 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... , May 24, 2013 The ... for systemic delivery of therapeutic agents has been receiving ... drug delivery showing significant promise. The crucial formulation considerations ... delivery device play a major role in the efficiency ... in the development of new formulation techniques and devices ...
(Date:5/23/2013)... WASHINGTON , May 23, 2013  Vanda Pharmaceuticals Inc. ... company has been named the 2013 Life Science Firm of ... (TCM).  Vanda was honored at the TCM,s 25 ... Bethesda , Maryland.  The Tech Awards Celebration recognizes the ... in Maryland and the surrounding regions. ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... Led to Important Clinical Trials, SANTA MONICA, ... and hyped the importance of its funding in,enabling ... severe blood disorder,Consumer Watchdog said today, seriously undercutting ... funded stem cell,research., Last week the California ...
... in April 2008 Issue of Contraception, ... announced results of a recently completed study ... noticeable,effects on women,s emotional well-being, prompted requests ... of emergency contraception. Results were,presented today in ...
Cached Medicine Technology:California Stem Cell Agency Exaggerated Its Role in Funding Key Research 2Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being 2Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being 3Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being 4Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being 5Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being 6
(Date:5/25/2013)... (PRWEB) May 25, 2013 On May 20, ... people do not wish to discuss or plan for their ... FuneralFinancials.com released a Must-Do List to help ... Funeral Financials recommends, “Creating a personal fact sheet.” , While ... organize financial information and personal data. It may include ...
(Date:5/25/2013)... York,NY (PRWEB) May 25, 2013 By ... officially declared the integration of the 2012 Lamborghini ... Aventador is the latest entrant in the list of ... intelligently, the vehicle is all set to thrill automobile ... vicious acceleration power and spectacular looks, the 2012 Lamborghini ...
(Date:5/25/2013)... Many orthodontists have thought about moving their ... cloud is. Most people would naturally assume that ... their cloud service and support would own and maintain ... selling, they'd be wrong. Cloud providers lease space ... facility that houses servers and related equipment to run ...
(Date:5/25/2013)... NJ (PRWEB) May 25, 2013 Acuity ... The universal app version of Word Hunt is ... versions of Concentration, Edge Match, Flash 2, Sudoku and Matchematics ... The brain games’ gameplay and revolutionary lifetime brain fitness measurement ... inch displays. , “100 years of brain fitness measurement in ...
(Date:5/25/2013)... Bradley, Illinois (PRWEB) May 25, 2013 ... assisted living community, is hosting an American Red Cross ... May 30. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... give the Gift of Life," says Andrea Arview Frey, ...
Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Acuity Games Apps Come to the iPhone 2Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2
... The ... by more than 30% to meet the growing demand by medical practitioners to enhance and ... ... -- The Laser Warehouse has increased its inventory of used cosmetic lasers and other used ...
... ... the public to share their personal stories and utilizes social media to spread the word. ... Newcastle, ME (Vocus) July 8, 2010 ... resulted in a special video project and upcoming book. The Social Security Stories Project ...
... Gardner HealthDay Reporter , THURSDAY, July 8 (HealthDay ... throat cancers may also raise the risk of developing squamous ... a new study suggests. The risk from human papillomavirus ... people are taking drugs such as glucocorticoids to suppress the ...
... ... care staff offer new career opportunities for ambitious professionals. , ... (PRWeb UK) July 9, 2010 -- HCL International, the leading ... high turnout of GPs and social workers interested in working in ...
... ... work helping sea turtle conservation efforts in Magdalena Bay with 3 days sea kayaking ... experience necessary. , ... Loreto, Baja California (PRWEB) July 9, 2010 -- Idaho-based Sea Kayak Adventures, Inc. is ...
... ... multi-platinum group the Jonas Brothers, was announced today as the National Chair of Juvenile ... ... Grammy-nominated, multi-platinum group the Jonas Brothers, was announced today as the National Chair of ...
Cached Medicine News:Health News:The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand 2Health News:The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand 3Health News:Project captures Social Security "Stories," Seeks Additional Submissions from Public 2Health News:Project captures Social Security "Stories," Seeks Additional Submissions from Public 3Health News:Study Suggests Link Between HPV, Skin Cancer 2Health News:Study Suggests Link Between HPV, Skin Cancer 3Health News:HCL International: Australia a Favourite Destination for UK Social Workers and GPs 2Health News:HCL International: Australia a Favourite Destination for UK Social Workers and GPs 3Health News:Help Save Sea Turtles and Kayak Loreto Baja this October 2Health News:Help Save Sea Turtles and Kayak Loreto Baja this October 3Health News:Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes 2Health News:Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes 3Health News:Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes 4
Iron / TIBC (Ferrozine). Storage temp: 2 - 8 C. Linearity: 0 - 500 ug/dl. Expected values: from TIBC 250 - 400 ug/dl, from Iron 40 - 160 ug/dl. Available with Calibrator and Number of test are 100....
Iron FS Ferene for determination of iron in serum. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P. For automated systems....
Iron UIBC (UIBC Buffer + Color + Std.). An Automated analyzer test kits....
Intended for the quantitative determination of iron in serum. Reaction: Endpoint. Wavelength: 595 nm. Linearity: 500 g/dL (89.5 mol/L). Two vials, liquid reagents....
Medicine Products: